This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Universitè De Genève. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Innovations of Nicolas Jean Page
Introduction
Nicolas Jean Page is a notable inventor based in Bonneville, France. He has made significant contributions to the field of virology, particularly in the development of vaccine vectors. His work focuses on the engineering of arenaviruses, which are crucial for advancing immunotherapy and vaccine development.
Latest Patents
Nicolas Jean Page holds a patent for "Tri-segmented arenaviruses as vaccine vectors." This patent describes arenaviruses with rearrangements of their open reading frames (ORF) in their genomes. Specifically, it details a modified arenavirus genomic segment that is engineered to carry a viral ORF in a position other than its wild-type position. The patent also discusses trisegmented arenavirus particles that comprise one L segment and two S segments or two L segments and one S segment. These arenaviruses may be suitable for vaccines and treatments of diseases, as well as for use in immunotherapies. He has 1 patent to his name.
Career Highlights
Nicolas Jean Page is affiliated with the Université de Genève, where he conducts his research and development work. His innovative approach to vaccine vectors has positioned him as a key figure in the field of virology.
Collaborations
He has collaborated with notable researchers such as Daniel David Pinschewer and Doron Merkler. Their joint efforts contribute to the advancement of knowledge and technology in the area of vaccine development.
Conclusion
Nicolas Jean Page's work in the field of arenaviruses and vaccine vectors showcases his innovative spirit and dedication to improving healthcare solutions. His contributions are vital for the future of immunotherapy and vaccine research.